NVDA facing competition from rivals like Intel, AMD, Qualcomm, Meta, Microsoft, and Google in AI hardware as they develop software to rival Nvidia's Cuda platform.
Planet Labs PBC (NYSE:PL), a leading provider of daily data and insights about Earth, today announced it has expanded its existing commercial partnership with BASF Digital Farming GmbH. Through this strategic
Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder valuePharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the
Data shows that the Trans-Arterial Micro-Perfusion (TAMP) platform increases intra-arterial pressure, improving drug delivery with 100-fold increase local tissue concentration of the therapyTAMP offers the potential to
Eli Lilly's diabetes drug tirzepatide receives approval in China, intensifying competition with Novo Nordisk's Ozempic. This move signals a significant expansion in the Asian market, where GLP-1 agonists are poised to drive a $2 billion market by 2030.
Goldman Sachs sees potential for further rise in Chinese stocks due to improving macroeconomic performance and policy support, with a 60% probability of continuing gains and potential average returns of 35% in the next 6 months.